Vistogard® is being distributed by BTG Pharmaceuticals as of July 1, 2023. For more details please click here.

Don’t wait to sound the alarm

Your life may depend on it

Severe reactions early in your 5-FU or capecitabine chemotherapy may signal a dangerous and potentially life-threatening toxic reaction.

The site will teach you and your caregivers:

  • How to recognize the signs of a severe or life-threatening reaction
  • What to do if you think you may be having a toxic reaction
  • The benefits of treating toxicity early and fast with Vistogard® (uridine triacetate)*, the first and only antidote for 5-FU or capecitabine toxicity
    *A pyrimidine analog.


Get armed with the facts

Help disarm 5-FU or
capecitabine chemotherapy toxicity

You are now leaving the patient site.

The section you selected contains information intended for U.S. healthcare professionals only.
Please certify that you are a U.S. healthcare professional by clicking the link below.